Campbell & CO Investment Adviser LLC Lexicon Pharmaceuticals, Inc. Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$1.95 - $3.89 $23,205 - $46,291	-11,900 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$3.81 - $6.16 $74,295 - $120,120	-19,500 Reduced 62.1%	11,900 $47,000
Q3 2021 Nov 10, 2021	BUY	$3.38 - $5.35 $106,132 - $167,990	31,400 New	31,400 $151,000
Q2 2021 Aug 11, 2021	SELL	$4.12 - $5.87 $424,772 - $605,197	-103,100 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.45 - $9.09 $355,695 - $937,179	103,100 New	103,100 $605,000
Q2 2019 Jul 10, 2019	SELL	$5.35 - $7.11 $114,329 - $151,940	-21,370 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$4.36 - $7.94 $93,173 - $169,677	21,370 New	21,370 $119,000

136

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $138M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.